With a lot more and a lot more individuals and firms exponentially becoming tuned into the positive aspects and legality of healthcare cannabis, the require for protected and legal access scales with such demand. Suitable now the Canopy Development Corporation is in the middle of a “green rush”, via the organizations ever expanding corporate portfolio, it creates and provides healthcare cannabis in Canada beneath a handful of brand names, such as Tweed, Spectrum Cannabis, Bedrocan, and Mettrum.
This week saw Canopy Development announce that the Corporation has signed definitive agreements to obtain Annabis Healthcare s.r.o (“Annabis Healthcare”), expanding the Company’s concentrate on a further emerging healthcare cannabis industry.
Annabis Healthcare is the leader in the Czech Republic’s healthcare cannabis market and at present imports and distributes cannabis items according to federal Czech licenses, with items for sale via pharmacy channels across the Czech Republic. Its founder and CEO, Dr Robin Kazík, will continue to lead and develop the Czech subsidiary as aspect of the bigger Canopy Development family members.
“This acquisition is a further instance of our commitment to expanding Canopy’s European presence and furthering our position of leadership,” stated Mark Zekulin, President, Canopy Development. “We appear forward to supplying Czech buyers with our higher top quality, GMP-developed healthcare cannabis items, and offering additional sources to assistance education for Czech pharmacists, individuals and healthcare practitioners.”
By combining Canopy Growth’s substantial worldwide expertise and network with the influential national position of Annabis Healthcare, Canopy is proud to bring its renowned Spectrum Cannabis brand to a further European industry.
“With a powerful footprint and established distribution network in the Czech healthcare cannabis industry, as properly as a history of importing Canadian cannabis, we are excited to join the Canopy Development family members. This move will permit us to a lot more quickly diversify our solution providing and strengthen our access to provide as we scale in the industry,” stated Dr Robin Kazík, Founder and CEO of Annabis Healthcare.
The acquisition of Annabis Healthcare will construct on Canopy Growth’s position of leadership in the European healthcare cannabis space and follows the current partnership and provide agreement with Spanish pharmaceutical leader Alcaliber S.A. On top of that, Canopy Development at present supplies the German industry via its subsidiary, Spektrum Cannabis GmbH, and has formed a partnership, Spectrum Cannabis Denmark ApS, which is licensed to cultivate cannabis in a 40,000 square meter greenhouse production facility positioned in Odense, Denmark. These assets, combined with Canopy Growth’s unparalleled Canadian production and sales platforms, represent the world’s biggest and most diversified cannabis platform.
Supply Canopy Development Corporation